Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2011-08-09
2011-08-09
Reddig, Peter J (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S323000, C530S326000, C530S327000, C530S328000, C514S001100, C514S019200, C514S019300, C514S019400, C514S019500
Reexamination Certificate
active
07994276
ABSTRACT:
The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against colorectal cancer.
REFERENCES:
patent: 6096313 (2000-08-01), Jager et al.
patent: 6623923 (2003-09-01), Xu et al.
patent: 6756038 (2004-06-01), Schlom et al.
patent: 2002/0102544 (2002-08-01), Mack et al.
patent: 2003/0017167 (2003-01-01), Jiang
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 2003/0109690 (2003-06-01), Ruben et al.
patent: 2004/0171543 (2004-09-01), Dublanchet et al.
patent: 2004/0265230 (2004-12-01), Martinez et al.
patent: 1760089 (2007-03-01), None
patent: 0006723 (2000-02-01), None
patent: 03025138 (2003-03-01), None
patent: 2006027693 (2006-03-01), None
patent: WO 2009/015841 (2009-05-01), None
Mologen Ag (dSLIM® Immunomdulators, 2010).
Silver (The Immune Response Co. 2004).
Linganu et al. (Expert Rev. Vaccines 2007: 6: 741-746).
Pearse and Drane (Vaccine 2004 22:2391-2395).
PRNewswire (Encoycopedia.com Mar. 1, 2006).
Podda et al. (Expert Rev. Vaccines, 2003 2: 197-203).
SEPPIC (www.montanide.com, 2010).
ONTAK® (denileukin diftitox, package insert, Sep. 2009).
Misseri, Y. (BT Pharma, S. A. 2007).
Taunoton-Rigby (PRNewswire, Aquila Biopharmaceuticals, Inc. www.highbeam.com 1997).
Celis (J. of Clinical Investigation, 2002, 110:1765-1768).
Marincola et al. (Trends in Immunology, Jun. 2003, 334-341).
Kirkin et al. (1998, APMIS, 106: 665-679).
Sherman et al. (Critical Reviews in Immunol. 1998, 18:47-54).
Smith (Clin. Immunol, 1994, 41(4): 841-849).
Harlin et al. (Caner Immunol. Immunotherap. 2006, 55:1185-1197).
Disis et al. (J. Immunol. 1996: 156:13151-3158).
Gura (Science, 1997, 278:1041-1042).
Kaiser (Science 2006, 31: 1370).
Schellens et al. (Eur. J. Pharmaceutical Sciences 2000, 12:103-110).
Taber's Cyclopedic Medical Dictionary (1985, F.A. Davis Company, Philadelphia, p. 274).
Busken, C et al. (Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No. 850).
Krontiris and Capizzi (Internal Medicine, 4th Edition, Editor-in-chief Jay Stein, Elsevier Science, 1994 Chapters 71-72, pp. 699-729.
Carter, S. K. et al. (Chemotherapy of Cancer; Second edition; John Wiley & Sons: New York, 1981; appendix C).
Bowie et al (Science, 1990, 247:1306-1310).
Skolnick et al. (TIBTECH 18:34-39, 2000).
Ibragimova and Eade (Biophysical Journal, Oct. 1999, vol. 77, pp. 2191-2198).
Rudikoff et al. (PNAS, USA, 1982, 79: 1979-1983).
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444).
Burgess et al (J. of Cell Bio. 111:2129-2138, 1990).
George et al. (2005, Trends in Immunology 26(12):653-659).
International Search Report for PCT/EP2008/006152, Dated Jan. 7, 2009.
International Search Report for EP 05019255, Dated Dec. 1, 2005.
H. W. Heid et al.: “Apidpocyte Differentiation-Related Protein is Secreted Into Milk as a Constituent of Milk Lipid Globule Membrane”, Biochemical Journal, Portland Press, London, GE, vol. 320, No. Part 3, Dec. 15, 1996, pp. 1025-1030, XP002060680, ISSN: 0264-6021; p. 1027; Figure 2.
J. Barnett et al.: “Production, Purification and Characterization of Human Matrilysin (Pump) From Recombinant Chinese Hamster Ovary Cells”. Protein Expression and Purification, vol. 5, 1994, pp. 27-36, XP002352893, p. 34; Table 2.
A.R. Welch et al.: “Purification of Human Matrilysin Produced inEscherichia coliand Characterization Using a New Optimized Fluorogenic Peptide Substrate”, Archives of Biochemistry and Biophysics, vol. 324, No. 1, 1995 pp. 59-64, XP002352894; p. 60; col. 1, Line 13-Line 17.
P. Brossart et al: “Identification of HLA-A2-Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies”, Blood, W.B. Saunders Company, Orlando, FL, US, vol. 93, No. 12, Jun. 15, 1999, pp. 4309-4317, XP 002147432, ISSN: 0006-4971, p. 4310, col. 1, Lin 53-Line 61.
Hilf Norbert
Lewandrowski Peter
Schoor Oliver
Singh Harpreet
Trautwein Claudia
Baker Donelson Bearman Caldwell & Berkowitz PC
Immatics Biotechnologies GmbH
Reddig Peter J
LandOfFree
Composition of tumour-associated peptides and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition of tumour-associated peptides and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition of tumour-associated peptides and related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2760720